Study of MLN9708 as Maintenance Therapy for Patients With Acute Myeloid Leukemia (AML) and High Risk Myelodysplastic Syndrome (MDS) in Remission
Clinical trial NCT02302846 · TERMINATED
Trial details
- NCT number
- NCT02302846
- Sponsor
- M.D. Anderson Cancer Center
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-03-20
- Primary completion
- 2017-05-30
- Enrollment
- 5
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.